Evidence map›Paper›PMID 40050291›Full record

ArticleNPJ systems biology and applications2025

An integrative phenotype-structured partial differential equation model for the population dynamics of epithelial-mesenchymal transition.

Jules Guilberteau, Paras Jain, Mohit Kumar Jolly, Camille Pouchol, Nastassia Pouradier Duteil

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jules Guilberteau *Sorbonne Université, CNRS, Université Paris Cité, Inria, Laboratoire Jacques-Louis Lions (LJLL), Paris, France.
Paras Jain *Department of Bioengineering, Indian Institute of Science, Bangalore, India.ORCID http://orcid.org/0000-0001-6057-7993
Mohit Kumar JollyDepartment of Bioengineering, Indian Institute of Science, Bangalore, India. mkjolly@iisc.ac.in.ORCID http://orcid.org/0000-0002-6631-2109
Camille PoucholUniversité Paris Cité, FP2M, CNRS FR 2036, MAP5 UMR 8145, Paris, France. camille.pouchol@u-paris.fr.
Nastassia Pouradier DuteilSorbonne Université, CNRS, Université Paris Cité, Inria, Laboratoire Jacques-Louis Lions (LJLL), Paris, France. nastassia.pouradier_duteil@sorbonne-universite.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenotypic heterogeneity along the epithelial-mesenchymal (E-M) axis contributes to cancer metastasis and drug resistance. Recent experimental efforts have collated detailed time-course data on the emergence and dynamics of E-M heterogeneity in a cell population. However, it remains unclear how different intra- and inter-cellular processes shape the dynamics of E-M heterogeneity. Here, using Cell Population Balance model, we capture the dynamics of cell density along E-M phenotypic axis resulting from interplay between-(a) intracellular regulatory interaction among biomolecules, (b) cell division and death and (c) stochastic cell-state transition. We find that while the existence of E-M heterogeneity depends on intracellular regulation, heterogeneity gets enhanced with stochastic cell-state transitions and diminished by growth rate differences. Further, resource competition among E-M cells can lead to both bi-phasic growth of the total population and/or bi-stability in the phenotypic composition. Overall, our model highlights complex interplay between cellular processes shaping dynamic patterns of E-M heterogeneity.

Indexed as

Epithelial-Mesenchymal TransitionModels, BiologicalHumansPhenotypeStochastic Processes

Identifiers

PMID40050291
PMCPMC11885588

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.